Low oxygen levels during brain development may cause particular cells to differentiate too soon, a Stanford-led study found.
May 6, 2019 - By Erin Digitale
Low oxygen levels are a well-known cause of brain injury in premature babies. But the mechanism by which low oxygen hurts the developing human brain has been unclear.
Now, researchers at the Stanford University School of Medicine have identified a specific set of brain cells that are particularly susceptible to harm from low oxygen exposure in early development. This damage is congruent with brain abnormalities, particularly reduction in gray matter, seen among children who are born very prematurely. The researchers have also identified a compound that may be able to prevent the problem. The findings were published online May 6 in Nature Medicine.
“In the past 20 years, we’ve made a lot of progress in keeping extremely premature babies alive, but 70% to 80% of them have poor neurodevelopmental outcomes,” said the study’s lead author, Anca Pasca, MD, assistant professor of pediatrics at the School of Medicine and a neonatologist at Lucile Packard Children’s Hospital Stanford. Hypoxic brain injuries are thought to lead to neurological and psychiatric disease in some preemies, she said.
Prior research has shown that children born before 28 weeks’ gestation, or at least 12 weeks early, have a thinner cerebral cortex than children born after a full-term pregnancy. The cerebral cortex is the highly folded layer of gray matter that makes up a large portion of the brain in humans and other primates. It is responsible for advanced brain functions, including cognition, speech and the processing of sensory and motor information.
Neonatologists have also long recognized that lung development is incomplete in very premature babies. The babies have poor lung function, and the brain centers that control the infants’ breathing are not fully mature. These factors raise their risk for drops in blood oxygen and subsequent brain injury.
Severely affected cells
Pasca and her colleagues found that many cells in the developing brain are unhurt by exposure to low oxygen. However, the intermediate progenitor cells of the subventricular zone, a region responsible the growth of the human cortex, are severely affected. These are cells that eventually give rise to mature brain cells, including neurons.
“Most of human brain development, specifically in the second and third trimesters of pregnancy, is inaccessible for direct study,” said senior author Sergiu Pasca, MD, assistant professor of psychiatry and behavioral sciences.
The discovery was possible because Sergiu and Anca Pasca — who are married to each other and each run a lab at Stanford — and their colleagues previously figured out how to create three-dimensional cell cultures that mimic structural and functional aspects of the parts of the developing human brain. They call these brain spheroids or organoids.
Sergiu and Anca Pasca have previously published studies showing that the brain spheroids resembling the cerebral cortex develop the same general organization, including deep and superficial layers of cortex, and on approximately the same timeline. “It is quite remarkable how these blobs of cells, if provided with the right cues, will differentiate, organize and mature in a dish,” Sergiu Pasca said.
In the new study, the team grew brain spheroids until they contained cell populations and gene-expression markers similar to human brain tissue midway through gestation.
The researchers exposed these cortical spheroids to low oxygen for 48 hours, then restored the oxygen levels. They examined changes in gene expression at 24 and 48 hours into the low-oxygen period, as well as 72 hours after oxygen levels had returned.
As expected, the scientists saw gene-expression changes after 24 and 48 hours in genes known to respond to hypoxia.
They also saw changes in a group of genes expressed in the subventricular zone, an area rich in progenitor cells that generate neurons in mid- and late pregnancy. Closer analysis showed these progenitor cells were not dying. Rather, they were differentiating into neurons sooner than normal, a change that could lead to fewer neurons in total in the mature brain. The pathway responsible, called the unfolded protein response, is a stress-response pathway that transitions cells from a “growth” mode to a “survival” mode.
“We were surprised, but it was a good surprise,” Anca Pasca said. “Looking back, it made sense.”
Testing a compound
The researchers also tested whether a small molecule that restores aspects of the unfolded protein response could reverse the brain spheroids’ response to low oxygen. The molecule, called ISRIB, prevented the reduction in intermediate progenitors following low-oxygen exposure.
“It’s exciting because our findings tell us that pharmacologically manipulating this pathway could interfere with hypoxic injury to the brain, and potentially help with preventing damage,” Sergiu Pasca said.
Other Stanford co-authors of the paper are research scientist Jin-Young Park, PhD; visiting associate professor Huyn-Woo Shin, MD, PhD; postdoctoral scholar Omer Revah, DVM, PhD; Ruth O’Hara, PhD, professor of psychiatry and behavioral sciences; and Theo Palmer, PhD, professor of neurosurgery.
Anca Pasca and Sergiu Pasca are members of the Stanford Maternal & Child Health Research Institute, the Wu Tsai Neurosciences Institute at Stanford and Stanford Bio-X. Sergiu Pasca is a fellow of Stanford ChEM-H, and a New York Stem Cell Foundation-Robertson investigator.
Scientists from Seoul National University and the University of California-San Francisco also contributed to the research.
The research was supported the National Institutes of Health (grants MH107800, K12-HD000850 and R01MH108659), the MQ Fellow Award, the New York Stem Cell Foundation, the Wu Tsai Neurosciences Institute, Stanford Bio-X, the Kwan Research Fund, the California Institute for Regenerative Medicine, the UCSF Weill Institute for Neurosciences, the Association of Medical School Pediatric Department Chairs and the Stanford Maternal & Child Health Research Institute.
Stanford’s departments of Pediatrics and of Psychiatry and Behavioral Sciences also supported the work.
About Stanford Medicine
Stanford Medicine is an integrated academic health system comprising the Stanford School of Medicine and adult and pediatric health care delivery systems. Together, they harness the full potential of biomedicine through collaborative research, education and clinical care for patients. For more information, please visit med.stanford.edu.